WO2005099763A3 - Composition for intracellular transfer of a nucleic acid - Google Patents
Composition for intracellular transfer of a nucleic acid Download PDFInfo
- Publication number
- WO2005099763A3 WO2005099763A3 PCT/FR2005/050252 FR2005050252W WO2005099763A3 WO 2005099763 A3 WO2005099763 A3 WO 2005099763A3 FR 2005050252 W FR2005050252 W FR 2005050252W WO 2005099763 A3 WO2005099763 A3 WO 2005099763A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- composition
- intracellular transfer
- efficient amount
- intracellular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0404010 | 2004-04-16 | ||
FR0404010A FR2868953B1 (en) | 2004-04-16 | 2004-04-16 | COMPOSITION FOR THE INTRACELLULAR TRANSFER OF A NUCLEIC ACID. |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005099763A2 WO2005099763A2 (en) | 2005-10-27 |
WO2005099763A3 true WO2005099763A3 (en) | 2006-04-13 |
Family
ID=34946275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2005/050252 WO2005099763A2 (en) | 2004-04-16 | 2005-04-15 | Composition for intracellular transfer of a nucleic acid |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2868953B1 (en) |
WO (1) | WO2005099763A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2021265103A1 (en) | 2020-04-29 | 2023-01-19 | Bristol-Myers Squibb Company | Miniaturized dystrophins having spectrin fusion domains and uses thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000051645A1 (en) * | 1999-03-02 | 2000-09-08 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Polymer compositions for polynucleotide delivery |
US6353055B1 (en) * | 1994-11-18 | 2002-03-05 | Supratek Pharma Inc. | Polynucleotide compositions |
WO2002067990A1 (en) * | 2001-02-19 | 2002-09-06 | Aventis Pasteur | Polynucleotide formulation for enhanced intracellular transfer |
WO2003066104A2 (en) * | 2002-02-08 | 2003-08-14 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Pharmaceutical composition which improves in vivo gene transfer |
-
2004
- 2004-04-16 FR FR0404010A patent/FR2868953B1/en not_active Expired - Fee Related
-
2005
- 2005-04-15 WO PCT/FR2005/050252 patent/WO2005099763A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6353055B1 (en) * | 1994-11-18 | 2002-03-05 | Supratek Pharma Inc. | Polynucleotide compositions |
WO2000051645A1 (en) * | 1999-03-02 | 2000-09-08 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Polymer compositions for polynucleotide delivery |
WO2002067990A1 (en) * | 2001-02-19 | 2002-09-06 | Aventis Pasteur | Polynucleotide formulation for enhanced intracellular transfer |
WO2003066104A2 (en) * | 2002-02-08 | 2003-08-14 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Pharmaceutical composition which improves in vivo gene transfer |
Non-Patent Citations (1)
Title |
---|
"Dulbecco's Modification of Eagle's Medium (DMEM)", pages 1 - 3, XP002366782, Retrieved from the Internet <URL:http://www.mpbio.com/ecom/docs/proddata.nsf/(webtds)/1642354> [retrieved on 20060208] * |
Also Published As
Publication number | Publication date |
---|---|
FR2868953B1 (en) | 2006-06-30 |
FR2868953A1 (en) | 2005-10-21 |
WO2005099763A2 (en) | 2005-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200309298B (en) | Skin-permeable selective cyclooxygenase-2 inhibitor composition. | |
EG25171A (en) | Herbicide compositions. | |
PL378935A1 (en) | High-strength, low viscosity herbicidal formulations of glyphosate | |
ZA200308717B (en) | Herbicidal composition. | |
AP1866A (en) | Torque transmission mechanism. | |
WO2003066104A3 (en) | Pharmaceutical composition which improves in vivo gene transfer | |
WO2005118071A3 (en) | Tetrahydropyridothiophenes | |
MXPA03007539A (en) | Herbicidal composition. | |
MXPA03009002A (en) | 5-halogen-6-phenyl-7-fluoralkylamino-triazolopyrimidines as fungicides. | |
WO2004113236A3 (en) | Uncoupling agents | |
WO2004108770A8 (en) | Low odor chain transfer agents for controlled radical polymerization | |
WO2005099763A3 (en) | Composition for intracellular transfer of a nucleic acid | |
WO2006027344A3 (en) | 3-oxa-10-aza-phenanthrenes as pde4 or pde3/4 inhibitors | |
WO2006108835A3 (en) | Use of polylysine in biocide formulations containing copper | |
WO2005075457A8 (en) | Phthalazinone-derivatives as pde4 inhibitors | |
MXPA03009409A (en) | Herbicidal composition. | |
WO2006117193A3 (en) | Receptor in dendritic cells | |
ITBO20010338A0 (en) | EQUIPMENT FOR PICKUP, TRANSFER AND RELEASE FLAT BLANKS | |
WO2005048715A3 (en) | Organophosphoric compounds and use thereof | |
AU2002341224A1 (en) | Ecological multipurpose weights for fishing | |
Qian et al. | Maximum weight triangulation of a special convex polygon | |
AU2003290733A1 (en) | Universal cage for sensors, particularly suitable for use with fluid level sensors | |
AU2004903129A0 (en) | Cheque exchange | |
AU2005900833A0 (en) | P.K.'s Quarterball | |
IL165461A0 (en) | 2,5-disubstituted 3-mercaptopentanoic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |